Quantitative Beutler test for newborn mass screening of galactosemia usinga fluorometric microplate reader

Citation
A. Fujimoto et al., Quantitative Beutler test for newborn mass screening of galactosemia usinga fluorometric microplate reader, CLIN CHEM, 46(6), 2000, pp. 806-810
Citations number
13
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICAL CHEMISTRY
ISSN journal
00099147 → ACNP
Volume
46
Issue
6
Year of publication
2000
Part
1
Pages
806 - 810
Database
ISI
SICI code
0009-9147(200006)46:6<806:QBTFNM>2.0.ZU;2-7
Abstract
Background: The Beutler enzyme spot test is an effective assay for newborn mass screening of galactosemia, but it is qualitative and relies on visual interpretation. We describe a quantitative, instrumental modification of th e assay. Methods: We modified the macroscopic visual Beutler enzyme spot test by add ing extraction of blood components from filter paper, deproteinization with acetone-methanol, and quantification and recording by a fluorescent microp late reader and personal computer. All handling was performed in microplate s. The measurement time was 90 min. Results: Fluorescence intensity (FI) of healthy controls correlated with he matocrit and gal actose-1-phosphate uridyltransferase (GALT) activity. Pati ents with GALT deficiency were distinguished clearly from healthy subjects and heterozygous carriers by Fl. FI decreased to 75% of the initial activit y after storage at 25 degrees C for 3 days and to 40% after storage at 37 d egrees C for 7 days. Screening of 46 742 newborns yielded I false-positive result (in a heterozygous carrier), I patient with glucose-6-phosphate dehy drogenase deficiency, and no apparent false negatives as judged by concurre nt measurements of galactose and galactose-l-phosphate. Conclusions: The quantitative Beutler test can provide precise GALT activit y in newborn mass screening, and can take into consideration the influence of high temperature and humidity, duration between sampling and testing, an d anemia. This method is clinically useful, simple, automated, and highly r eliable for newborn mass screening of galactosemia. (C) 2000 American Assoc iation for Clinical Chemistry.